Faeth Therapeutics

FTHNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$860.228 M

$33.29 -3.51%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$21.1M

Loss-making

Shares outstanding

25,840,425

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#167Avalo TherapeuticsAVTX$867.2M
#168InventivaIVA$862.4M
#169Faeth TherapeuticsFTH$860.2M
#170CybinHELP$846.7M
#171Olema PharmaceuticalsOLMA$842.6M

What if Faeth Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,171,577

Per share 35,193× higher

Bitcoin $1.72T

$66,554.78

Per share 1,999× higher

Nvidia $5.48T

$212,065.32

Per share 6,370× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Faeth Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.